The Global Thyroid Eye Disease Treatments Market Is Witnessing Increasing Demand from the Healthcare Sectors Owing To the Incidence Rate of the Disease Worldwide

 

Thyroid eye disease treatments are specially curated for patients going through this severe health condition. Thyroid eye disease sometimes runs in the same family and is genetic. One can have thyroid disease and go on living a normal life and yet still have vision problems. In some cases, the hyperthyroidism patient can go for years without having eye problems but are always at risk of going completely blind. This is what can happen when the thyroid hormone that the patient is taking does not get to where it needs to be to make the patient's eyes work properly and this is the time when thyroid eye disease treatments are needed.

The relation to the thyroid is increasing every day across the globe. For instance, according to the American Thyroid Association, globally, around 1 billion individuals are always at risk for iodine deficiency that leads to thyroid disease. It has been estimated that around 200 million individuals worldwide have some form of thyroid disease. Thyroids are more prevalent in women than in men. Thyroid problems can be caused owing to a deficiency of iodine. The thyroid glands generate hormones that help to keep the body function normally.

The two main hormones generated by these glands are triiodothyronine (T3) and thyroxine (T4). When both these hormones are generated more or less than the accurate amount, the individual can get diagnosed with hyperthyroid and hypothyroid, respectively. Owing to all these factors, there has been a constant requirement for treatments related to thyroid diseases and their side effects, which also created significant demand in the global thyroid eye disease treatment market. Moreover, key manufacturers of thyroid eye disease treatment devices are focused on strengthening their position in the market with agreements, acquisitions, and strategic mergers, which is aiding the growth of the global thyroid eye disease treatment market. However, less awareness related to this disease is the main factor that is restraining the growth of the global thyroid eye disease treatment market.

In recent times, North America has been witnessing an increasing rate of thyroid eye disease among the residents. For instance, according to W.K. Kellogg Eye Center, every year around 1 million U.S. residents get diagnosed with thyroid eye disease and women are more vulnerable to the disease than men. Owing to all these and backed up by favorable medical insurances and government aid, the demand in the thyroid eye disease treatment market is increasing every day. In the Asia Pacific regions, rising awareness regarding thyroid eye disease and government initiatives towards helping the patients is creating significant demand in the thyroid eye disease treatment market. Owing to all these factors, there have been some significant industrial developments in the global thyroid eye disease treatment market, over the last few years. For instance, in January 2020, Tepezza made by Horizon Therapeutics plc got approved by the U.S. Food and Drug Administration (FDA). Tepezza is used for treating thyroid eye disease.